Your browser doesn't support javascript.
loading
The CDR3 region as the major driver of TREM-1 interaction with its ligands, an in silico characterization.
de Oliveira Matos, Amanda; Dos Santos Dantas, Pedro Henrique; Colmenares, Mike Telemaco Contreras; Sartori, Geraldo Rodrigues; Silva-Sales, Marcelle; Da Silva, João Herminio Martins; Neves, Bruno Junior; Andrade, Carolina Horta; Sales-Campos, Helioswilton.
Afiliação
  • de Oliveira Matos A; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
  • Dos Santos Dantas PH; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
  • Colmenares MTC; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
  • Sartori GR; FIOCRUZ-Ceará, Fundação Oswaldo Cruz - Ceará, Eusébio, Brazil.
  • Silva-Sales M; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
  • Da Silva JHM; FIOCRUZ-Ceará, Fundação Oswaldo Cruz - Ceará, Eusébio, Brazil.
  • Neves BJ; LabMol - Laboratory for Molecular Modeling and Drug Design, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, Brazil.
  • Andrade CH; LabMol - Laboratory for Molecular Modeling and Drug Design, Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, Brazil.
  • Sales-Campos H; Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil.
Comput Struct Biotechnol J ; 21: 2579-2590, 2023.
Article em En | MEDLINE | ID: mdl-37122631
ABSTRACT
The triggering receptor expressed on myeloid cells-1 (TREM-1) is a pattern recognition receptor heavily investigated in infectious and non-infectious diseases. Because of its role in amplifying inflammation, TREM-1 has been explored as a diagnostic/prognostic biomarker. Further, as the receptor has been implicated in the pathophysiology of several diseases, therapies aiming at modulating its activity represent a promising strategy to constrain uncontrolled inflammatory or infectious diseases. Despite this, several aspects concerning its interaction with ligands and activation process, remain unclear. Although many molecules have been suggested as TREM-1 ligands, only five have been confirmed to interact with the receptor actin, eCIRP, HMGB1, Hsp70 and PGLYRP1. However, the domains involved in the interaction between the receptor and these proteins are not clarified yet. Therefore, here we used in silico approaches to investigate the putative binding domains in the receptor, using hot spots analysis, molecular docking and molecular dynamics simulations between TREM-1 and its five known ligands. Our results indicated the complementarity-determining regions (CDRs) of the receptor as the main mediators of antigen recognition, especially the CDR3 loop. We believe that our study could be used as structural basis for the elucidation of TREM-1's recognition process, and may be useful for prospective in silico and biological investigations exploring the receptor in different contexts.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article